Merck & Co., Inc. Receivables, Net, Current
Merck & Co., Inc. (MRK) had Receivables, Net, Current of $7.96 billion as of 2011-03-31, per its 10-Q filed 2011-05-09.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:ReceivablesNetCurrent · last filed 2011-05-09
- 2011-03-31: Receivables, Net, Current $7.96B.
- 2010-12-31: Receivables, Net, Current $7.34B.
- 2010-09-30: Receivables, Net, Current $7.30B.
- 2010-06-30: Receivables, Net, Current $6.28B.
| Period end | Receivables, Net, Current | Receivables, Net, Current as first filed |
|---|---|---|
| 2011-03-31 | $7.96B 10-Q · filed 2011-05-09 | |
| 2010-12-31 | $7.34B 10-Q · filed 2011-05-09 | |
| 2010-09-30 | $7.30B 10-Q · filed 2010-11-08 | |
| 2010-06-30 | $6.28B 10-Q · filed 2010-08-06 | |
| 2010-03-31 | $7.50B 10-Q · filed 2010-05-07 | |
| 2009-12-31 | $6.60B 10-K · filed 2011-02-28 | $6.60B 10-K · filed 2010-03-01 |
| 2008-12-31 | $2.91B 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |